The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Outcome of pregnancy in women with valve prostheses.
Open accessAbstract
OBJECTIVE: To study the outcome of pregnancy in women with artificial heart valves treated in major European centres, and to compare the safety and efficacy of different anticoagulant regimens and of mechanical and bioprosthetic valves. DESIGN: Retrospective study. METHOD: The information was obtained by questionnaire sent to all major cardiac centres in Europe sending one cardiologist from each centre a covering letter suggesting that the questionnaire be handed on where appropriate to the most relevant colleague. RESULTS: 214 pregnancies were reported in 182 women; 151 pregnancies in 133 women with mechanical valves, and 63 pregnancies in 45 women with bioprostheses. Most women were in New York Heart Association class I or II and in sinus rhythm. 150 women with mechanical valves and 11 (17%) with bioprostheses received anticoagulants during pregnancy. One patient with an aortic valve prosthesis refused to take anticoagulants. Including the spontaneous abortions reported as well as the therapeutic abortions 83% of the pregnancies in women with bioprostheses and 73% in those with mechanical valves resulted in a healthy baby, full term or premature, who did well (NS). The incidence of stillbirths (3% and 6%) and of reported spontaneous abortions are excluded (because they are unlikely to have been fully reported), the success rate was 91% for women with bioprosthetic valves and 84% for women with mechanical valves (NS). 114 (53%) of the women had taken warfarin for some part of the pregnancy (46 (40%) of these during the first trimester) but there were no embryopathies. There were 13 valve thromboses (four fatal), eight embolic events (two fatal), and seven bleeds in women with mechanical valves. Most of these complications occurred with heparin but fatal aortic valve thrombosis occurred in the one woman who refused anticoagulant treatment out of the 151 women with mechanical valves. There were no maternal deaths in the bioprosthesis group but in 17/49 (35%) of these valves functional deterioration led to urgent replacement during pregnancy (two) or soon after. CONCLUSIONS: The outcome of pregnancy was similar for women with mechanical valves or bioprostheses. Warfarin treatment was safe and effective and was not associated with embryopathy. Heparin treatment was associated with more thromboembolic complications and more bleeding complications. Bioprostheses deteriorate rapidly during pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SCHAFER, A. I. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-6-814 · Cited by 415
Risks of Anticoagulant Therapy in Pregnant Women with Artificial Heart Valves
Iturbe-Alessio, I., Fonseca, M. D. C., Mutchinik, O., Santos, M. A., Zajarías, A., & Salazar, E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611273152205 · Cited by 307
Heparin Therapy During Pregnancy: Risks to the Fetus and Mother
Ginsberg, J. S. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390100059015 · Cited by 200
Hazards of Oral Anticoagulants During Pregnancy
Stevenson, R. E. (1980) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1980.03300410037022 · Cited by 172
The spontaneous occurrence of paroxysmal supraventricular tachycardia.
Pritchett, E. L., Smith, M. S., McCarthy, E. A., & Lee, K. L. (1984) · Circulation · doi:10.1161/01.cir.70.1.1 · Cited by 165
The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial
Howell, R. J. S., Fidler, J., Letsky, E. A., & de Swiet, M. (1983) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1983.tb06458.x · Cited by 153
The problem of cardiac valve prostheses, anticoagulants, and pregnancy.
Salazar, E. J., Zajarías, A., Gutierrez, N., et al. (1984) · PubMed · Cited by 115
Pregnancy and Mechanical Valve Prostheses: A High-Risk Situation for the Mother and the Fetus
Larrea, J. L., Núñez, L., Reque, J. A., Aguado, M. G., Matarros, R., & Mínguez, J. Á. (1983) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)60488-2 · Cited by 81
Pregnancy in Patients with Prosthetic Heart Valves: An Experience with 45 Pregnancies
Chen, W. W. C., Chan, C., Lee, P., Wang, R. Y. C., & WONG, V. C. W. (1982) · QJM · doi:10.1093/oxfordjournals.qjmed.a067728 · Cited by 78
Anticoagulants During Pregnancy
Ginsberg, J. S., & Hirsh, J. (1989) · Annual Review of Medicine · doi:10.1146/annurev.me.40.020189.000455 · Cited by 72
Cited by
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,495
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,905
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000029 · Cited by 2,566
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.007 · Cited by 2,257
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.018 · Cited by 1,982
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.021 · Cited by 1,702
ACC/AHA guidelines for the management of patients with valvular heart disease
Bonow, R., Carabello, B., de Leon, A., Edmunds, L. H., Fedderly, B., Freed, M., Gaasch, W., McKay, C., Nishimura, R., O’Gara, P., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00454-9 · Cited by 1,134
2006 WRITING COMMITTEE MEMBERS, Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.190748 · Cited by 1,114
2014 AHA/ACC guideline for the management of patients with valvular heart disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.05.014 · Cited by 989
American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy
Hirsh, J., Fuster, V., Ansell, J., & Halperin, J. L. (2003) · Circulation · doi:10.1161/01.cir.0000063575.17904.4e · Cited by 911
Chan, W. S., Anand, S., & Ginsberg, J. S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.2.191 · Cited by 749
Predictors of pregnancy complications in women with congenital heart disease
Drenthen, W., Boersma, E., Balci, A., Moons, P., Roos-Hesselink, J. W., Mulder, B. J. M., Vliegen, H. W., van Dijk, A. P. J., Voors, A. A., Yap, S. C., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq200 · Cited by 706
Use of Antithrombotic Agents During Pregnancy
Ginsberg, J. S., & Hirsh, J. (1995) · Chest · doi:10.1378/chest.108.4_supplement.305s · Cited by 657
Use of Antithrombotic Agents During Pregnancy
Bates, S. M., Greer, I. A., Hirsh, J., & Ginsberg, J. S. (2004) · Chest · doi:10.1378/chest.126.3_suppl.627s · Cited by 552
Management of Grown Up Congenital Heart Disease
Deanfield, J. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00131-3 · Cited by 513
Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves
Vitale, N., De Feo, M., De Santo, L. S., Pollice, A., Tedesco, N., & Cotrufo, M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00044-3 · Cited by 492
Canobbio, M. M., Warnes, C. A., Aboulhosn, J., Connolly, H. M., Khanna, A., Koos, B. J., Mital, S., Rose, C., Silversides, C., & Stout, K. (2017) · Circulation · doi:10.1161/cir.0000000000000458 · Cited by 475
Recommendations for the management of patients after heart valve surgery
Butchart, E. G., Gohlke-Bärwolf, C., Antunes, M. J., Tornos, P., De Caterina, R., Cormier, B., Prendergast, B., Iung, B., Bjornstad, H., Leport, C., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi426 · Cited by 358
Acute Myocardial Infarction Associated with Pregnancy
Roth, A., & Elkayam, U. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-9-199611010-00009 · Cited by 349
Outcome of cardiovascular surgery and pregnancy: A systematic review of the period 1984-1996
Weiss, B. M., von Segesser, L. K., Alon, E., Seifert, B., & Turina, M. I. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70039-0 · Cited by 309
Hirsh, J., Fuster, V., Ansell, J., & Halperin, J. L. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00416-9 · Cited by 306
Use of Antithrombotic Agents During Pregnancy
Ginsberg, J. S., Greer, I., & Hirsh, J. (2001) · Chest · doi:10.1378/chest.119.1_suppl.122s · Cited by 280
Valvular Heart Disease and Pregnancy
Elkayam, U., & Bitar, F. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.087 · Cited by 275
Pregnancy in patients with heart disease: Experience with 1,000 cases
Avila, W. S., Rossi, E. G., Ramires, J. A. F., Grinberg, M., Bortolotto, M. R. L., Zugaib, M., & Luz, P. L. D. (2003) · Clinical Cardiology · doi:10.1002/clc.4960260308 · Cited by 273
2020 ACC/AHA guideline for the management of patients with valvular heart disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.002 · Cited by 279
Metadata
- Authors
- Sbarouni, E., & Oakley, C. M.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 1994-02-01
- Volume
- 71
- Issue
- 2
- Pages
- 196-201
- ISSN
- 1355-6037 (ISSN-L)
- OpenAlex
- W2015354888
- Cited by
- 305
- References
- 23
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.